These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 10569694

  • 21. The targets of the lytic antibody response against Trypanosoma cruzi.
    Krautz GM, Kissinger JC, Krettli AU.
    Parasitol Today; 2000 Jan; 16(1):31-4. PubMed ID: 10637586
    [Abstract] [Full Text] [Related]

  • 22. Changes of anti-Trypanosoma cruzi antibodies after gamma-irradiation of mice in the chronic phase of the infection.
    Umekita LF, Leite RA, Barbaro KC, Mota I.
    Acta Trop; 2000 Mar 25; 75(2):211-7. PubMed ID: 10708661
    [Abstract] [Full Text] [Related]

  • 23. IgG subclasses responsible for immune clearance in mice infected with Trypanosoma cruzi.
    Brodskyn CI, Silva AM, Takehara HA, Mota I.
    Immunol Cell Biol; 1989 Dec 25; 67 ( Pt 6)():343-8. PubMed ID: 2516504
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites.
    Pérez Brandán C, Mesías AC, Parodi C, Cimino RO, Pérez Brandán C, Diosque P, Basombrío MÁ.
    BMC Infect Dis; 2017 Nov 25; 17(1):732. PubMed ID: 29178839
    [Abstract] [Full Text] [Related]

  • 26. Role of membrane-bound IgM in Trypanosoma cruzi evasion from immune clearance.
    Garcia IE, Lima MR, Marinho CR, Kipnis TL, Furtado GC, Alvarez JM.
    J Parasitol; 1997 Apr 25; 83(2):230-3. PubMed ID: 9105302
    [Abstract] [Full Text] [Related]

  • 27. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
    Saldaña A, Sousa OE.
    J Parasitol; 1996 Apr 25; 82(2):363-6. PubMed ID: 8604121
    [Abstract] [Full Text] [Related]

  • 28. A radiometric assay for diagnosing lytic antibodies in Trypanosoma cruzi infection.
    Cardoni RL, Rottenberg ME, Segura EL.
    Parasitol Res; 1988 Apr 25; 74(6):512-5. PubMed ID: 3143107
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of trypomastigotes' infectivity by a monoclonal antibody directed to a glycoconjugated fraction of epimastigotes of Trypanosoma cruzi.
    Imaz MS, Esteva M, Velázquez E, Ruiz AM, Segura EL, Marcipar AJ.
    Rev Latinoam Microbiol; 1997 Apr 25; 39(1-2):33-46. PubMed ID: 10932713
    [Abstract] [Full Text] [Related]

  • 30. Trypanosoma cruzi: isolate dependence in the induction of lytic antibodies in the mouse and rabbit.
    Muller LA, Añasco N, González Cappa SM.
    Exp Parasitol; 1986 Jun 25; 61(3):284-93. PubMed ID: 3086113
    [Abstract] [Full Text] [Related]

  • 31. Carbohydrate epitopes are responsible for antibody cross-reactivity in Trypanosoma cruzi-infected mice.
    Xu BX, Powell MR.
    J Parasitol; 1991 Oct 25; 77(5):808-10. PubMed ID: 1717672
    [Abstract] [Full Text] [Related]

  • 32. Monoclonal antibodies mediating viable immunofluorescence and protection against Trypanosoma cruzi infection.
    Heath AW, Martins MS, Hudson L.
    Trop Med Parasitol; 1990 Dec 25; 41(4):425-8. PubMed ID: 2127473
    [Abstract] [Full Text] [Related]

  • 33. Humoral immune response to the Trypanosoma cruzi complement regulatory protein as an indicator of parasitologic clearance in human Chagas' disease.
    Norris KA, Galvão LM, Schrimpf JE, Cançado JR, Krettli AU.
    Infect Immun; 1994 Sep 25; 62(9):4072-4. PubMed ID: 8063427
    [Abstract] [Full Text] [Related]

  • 34. Glycoconjugates of Trypanosoma cruzi: a 74 kD antigen of trypomastigotes specifically reacts with lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas disease.
    Almeida IC, Krautz GM, Krettli AU, Travassos LR.
    J Clin Lab Anal; 1993 Sep 25; 7(6):307-16. PubMed ID: 8277354
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Monoclonal antibodies against the flagellar fraction of epimastigotes of Trypanosoma cruzi: immunoprotection against metacyclic trypomastigotes obtained by immunization of mice with an affinity-purified antigen.
    Ruiz AM, Esteva M, Subias E, Moreno M, Rosenstein de Campanini A, Velazquez E, Segura EL.
    Mol Biochem Parasitol; 1990 Feb 25; 39(1):117-25. PubMed ID: 2106075
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Characterization of major surface and excretory-secretory immunogens of Trypanosoma cruzi trypomastigotes and identification of potential protective antigen.
    Ouaissi MA, Taibi A, Cornette J, Velge P, Marty B, Loyens M, Esteva M, Rizvi FS, Capron A.
    Parasitology; 1990 Feb 25; 100 Pt 1():115-24. PubMed ID: 2107503
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.